Oral Answers to Questions

Andrew Rosindell Excerpts

Tuesday 7th February 2017 Commons Chamber

[David Mowat]

The vision set out in the GP five year forward view is of substantially more spend in the community and of an increase, as a proportion, in the amount of money in the NHS going to people in primary care. Part of that will be in polyclinics and the estate generally. As I say, one of the most innovative things we have found in the GP vanguards is that when they start to put together groups of 30,000, 40,000 and 50,000 patients in a GP hub, the quality of care increases dramatically. We are going to accelerate that.

[Andrew Rosindell (Romford) (Con)]

9. What plans the Government have to increase access for patients to innovative drugs and medical devices.

[The Parliamentary Under-Secretary of State for Health (Nicola Blackwood)]

The challenges facing our health system are significant, so we do need to improve the uptake of those innovative technologies that can improve efficiency and patient outcomes to help to meet that challenge, while also providing a pool for investment for innovators. By capitalising on advances in genomics, data, digital health and informatics, the accelerated access review will improve access to cost-effective new products.

[Andrew Rosindell]

I know that the Minister will agree with me when I say that it is vital that we endeavour to ensure that the NHS gets better value for money for the drugs bill so that we can afford to get more of the latest innovative products to patients more quickly, but does she also agree that much more work needs to be done alongside the accelerated access review and the forthcoming life sciences strategy to achieve that objective?

[Nicola Blackwood]

I completely agree with my hon. Friend. Medicines are the second highest area of spending in the NHS after staff, and it is vital that the NHS gets best value from that investment. That is why I am pleased that the House supported our recent Bill on the cost of medicines and medicine supplies, which will enable us to tackle unjustified price rises for unbranded generic medicines. We are also working closely with NHS England to promote the use of the new wave of biosimilar medicines and to ensure cost-effective prescribing behaviour.

National Minimum Wage: Care Sector

Andrew Rosindell Excerpts

Wednesday 23rd March 2016 Westminster Hall

[Several hon. Members rose—]

[Andrew Rosindell (in the Chair)]

I advise the House that a number of Members wish to speak. There is only limited time, so I urge Members to be brief and to keep their contributions to no more than three or four minutes each. I hope that then everyone will be able to speak.

--- Later in debate ---

[Andrew Rosindell (in the Chair)]

There will now be a time limit of three minutes to allow everyone to speak.

Male Suicide and International Men’s Day

Andrew Rosindell Excerpts

Thursday 19th November 2015 Westminster Hall

[The Minister for Community and Social Care (Alistair Burt)]

It is a pleasure to serve under your chairmanship, Mr Rosindell. Do I have until half-past 4?

[Andrew Rosindell (in the Chair)]

Yes.

[Alistair Burt]

It is nice to get a reasonable amount of time without being shouted at for spending a bit of time on my feet. I am pleased to be in that position today.